Neurogenic Vasoconstriction

Abstract

This paper is part of a series using a mechanism design approach for the analysis of medical markets. The first paper presented the way such an approach can help to analyze interactions between patients and physicians in different types of healthcare organizations (Huttin, 2021 and Cormsis seminar, 2021). This second paper provides a mapping of main players, using the US R&D eco system for a representation of actors. It also highlights possible links with the emerging theory of Transaction Cost Politics to understand the role of politics in the policy design and possible systemic changes in the institutional design of countries with strong R&D space for biopharmaceuticals. Rapid adoption of IT by professions, industry players, government agencies and patients will need new economics for health policies and healthcare management.